2000 – Present
Wu WY, Tabar L, Tot T, Fann CY, Yen AM, Chen SL, Chiu SY, Ku MM, Hsu CY, Beckmann KR, Smith RA, Duffy SW, Chen HH. Imaging Biomarkers as Predictors for Breast Cancer Death. J Oncol. 2019 Apr 10;2019:2087983. doi: 10.1155/2019/2087983. eCollection 2019.
Fann JC, Chang KJ, Hsu CY, Yen AM, Yu CP, Chen SL, Kuo WH, Tabár L, Chen HH. Impact of Overdiagnosis on Long-Term Breast Cancer Survival. Cancers (Basel). 2019 Mar 7;11(3). pii: E325. doi: 10.3390/cancers11030325.
Duffy SW, Smith RA, Tabár L, Dean PB, Chen TH. Reply to The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. 2019 Jun 15;125(12):2130-2131. doi: 10.1002/cncr.32007. Epub 2019 Feb 12. No abstract available.
Tabár L, Dean PB, Chen TH, Yen AM, Chen SL, Fann JC, Chiu SY, Ku MM, Wu WY, Hsu CY, Chen YC, Beckmann K, Smith RA, Duffy SW. The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening. Cancer. 2019 Feb 15;125(4):515-523. doi: 10.1002/cncr.31840. Epub 2018 Nov 8.
Tabar L, Chen TH, Yen AM, Chen SL, Fann JC, Chiu SY, Ku MMS, Wu WY, Hsu CY, Chen YY, Beckmann K, Smith RA, Duffy SW. Effect of Mammography Screening on Mortality by Histological Grade. Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):154-157. doi: 10.1158/1055-9965.EPI-17-0487. Epub 2017 Nov 17.
Yen AM, Wu WY, Tabar L, Duffy SW, Smith RA, Chen HH. Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer. J Epidemiol. 2017 Mar;27(3):98-106. doi: 10.1016/j.je.2016.10.003. Epub 2016 Nov 28.
Tabar L, Chen TH, Hsu CY, Wu WY, Yen AM, Chen SL, Chiu SY, Fann JC, Beckmann K, Smith RA, Duffy SW. Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review. J Med Screen. 2017 Mar;24(1):27-33. doi: 10.1177/0969141316631375. Epub 2016 Jun 23.
Tabar L, MD, Smith RA.. How effective are breast cancer screening programmes? In: Textbook of Gynecological Oncology, Chapter 199, Gunez Publishing, Ankara, Turkey, 2017.
Tabár L. Wrong conclusion about overdiagnosis in screening for breast cancer. Lakartidningen. 2015 Dec 23;112. pii: DTUS. Swedish.
Tsau HS, Yen AM, Fann JC, Wu WY, Yu CP, Chen SL, Chiu SY, Tabár L, Kuo WH, Chen HH, Chang KJ. Mammographic tumour appearance and triple-negative breast cancer associated with long-term prognosis of breast cancer death: A Swedish Cohort Study. Cancer Epidemiology 02/2015; 39(2). DOI:10.1016/j.canep.2015.01.013
Tabar L, Day N, Smith R, Chen TH, Yen AM, Duffy S. Systematic review of the breast cancer screening trials is error-ridden. J R Soc Med. 2015 Nov;108(11):430-1. doi: 10.1177/0141076815620070.
Tabár L, Chen HH, Yen AM, Chen SL, Fann JC, Chiu SY, Smith RA, Duffy SW. Response to Miller et al. The Breast Journal 05/2015; DOI:10.1111/tbj.12439.
Tabár L, Dean PB, Chen SL, Chen HH, Yen AM, Fann JC, Chiu SY, Smith RA and Duffy SW. Invasive Lobular Carcinoma of the Breast: The Use of Radiological Appearance to Classify Tumor Subtypes for Better Prediction of Long-Term Outcome. J Clin Exp Pathol 2014, 4:4 http://dx.doi.org/10.4172/2161-0681.1000179
Tabár L, Yen AM, Wu WY, Chen SL, Chiu SY, Fann JC, Ku MM, Smith RA, Duffy SW, Chen TH. Insights from the Breast Cancer Screening Trials: How Screening Affects the Natural History of Breast Cancer and Implications for Evaluating Service Screening Programs. The Breast Journal 11/2014; 21(1). DOI:10.1111/tbj.12354
Tabár L, Dean PB, Chen Hsiu-Hsi, Yen AM, Chiu SY, Tibor Tot, Smith RA, Duffy SW. The impact of mammography screening on the diagnosis and management of early phase breast cancer. In: Francescatti, Darius S.; Silverstein, Melvin J. (Eds.) Breast Cancer. A New Era in Management. 2014, Chapter 2. pp 31-78.
Smith RA, Duffy SW, Chen TH, Yen AMF, Tabar L. Abstract S1-10: Disparities in the estimates of benefits and harms from mammography: Are the numbers really different? Cancer Research 03/2014; 73(24 Supplement):S1-10-S1-10. DOI:10.1158/0008-5472.SABCS13-S1-10
Tabár L. Mammography screening study hampered by inadequate data. BMJ. 2014 Nov 25;349:g6823. doi: 10.1136/bmj.g6823. No abstract available.
Chuang SL, Chen SL, Yu CP, Chang KJ, Yen AM, Chiu SY, Fann JC, Tabár L, Stephen DW, Smith RA, Chen HH.. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers. Apmis 08/2014; 122(8). DOI:10.1111/apm.12294
Tabár L, Dean PB, Yen AM, Tarján M, Chiu SY, Chen SL, Fann JC, Chen TH. A Proposal to Unify the Classification of Breast and Prostate Cancers Based on the Anatomic Site of Cancer Origin and on Long-term Patient Outcome. Breast cancer 02/2014; 8:15-38. DOI:10.4137/BCBCR.S13833
Brem RF, Tabár L, Duffy SW, Inciardi MF, Guingrich JA, Hashimoto BE, Lander MR, Lapidus RL, Peterson MK, Rapelyea JA, Roux S, Schilling KJ, Shah BA, Torrente J, Wynn RT, Miller DP. Assessing Improvement in Detection of Breast Cancer with Three-dimensional Automated Breast US in Women with Dense Breast Tissue: The SomoInsight Study. Radiology. 2015 Mar;274(3):663-73. doi: 10.1148/radiol.14132832. Epub 2014 Oct 17.
Holmberg L, Wong YN, Tabár L, Ringberg A, Karlsson P, Arnesson LG, Sandelin K, Anderson H, Garmo H, Emdin S. Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study. Br J Cancer. 2013 Mar 5;108(4):812-9. doi: 10.1038/bjc.2013.26. Epub 2013 Jan 31.
Smith RA, Wu WY-Y, Tabár L, Chen SL-S, Yen AM-F, Duffy SW, Tot T, Chiu SY-H, Fann JC-Y, Chen TH-H. Abstract P4-03-07: The contribution of mammographic appearance, basal-like phenotype, and disease extent to prediction of breast cancer death. Cancer Research 12/2013; 73(24 Supplement):P4-03-07-P4-03-07. DOI:10.1158/0008-5472.SABCS13-P4-03-07.
Duffy SW, Chen TH-H, Smith RA, Yen AMF, Tabár L. Real and artificial controversies in breast cancer screening. 11/2013; 2(6):519-528. DOI:10.2217/bmt.13.53
Tan T, Platel B, Mus R, Tabár L, Mann RM, Karssemeijer N. Computer-aided detection of cancer in automated 3-D breast ultrasound. IEEE Trans Med Imaging. 2013 Sep;32(9):1698-706. doi: 10.1109/TMI.2013.2263389. Epub 2013 May 16.
Duffy SW, Yen AMF, Chen TH-H, Chen SSheng, Chiu SYH, Fan JJY, Smith RA, Vitak B, Tabár L. Long-term benefits of breast screening. 05/2012; 1(1):31-38. DOI:10.2217/bmt.12.8
Tabár L, Duffy SW, Viták B, Chen TH-H, Krusemo UB. The Swedish Two-County Trial 20-years on: updated mortality results and new insights from long-term follow-up. Breast Cancer Research (Impact Factor: 5.33). 04/2012; 2:1-1. DOI: 10.1186/bcr197.
Holmberg L, Wong YN, Tabár L, Ringberg A, Karlsson P, Arnesson LG, Sandelin K, Anderson H, Garmo H, Emdin S. Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study. Br J Cancer. 2013 Jan 31. doi: 10.1038/bjc.2013.26
Tabár L, Dean PB Mammography’s alleged harms: Separating fact from fiction. AuntMinnie.com. 2012 Dec 13
Pekar G, Hofmeyer S, Tabár L, Tarján M, Chen TH, Yen AM, Chiu SY, Hellberg D, Gere M, Tot T. Multifocal breast cancer documented in large-format histology sections: Long-term follow-up results by molecular phenotypes. Cancer. 2012 Dec 27. doi: 10.1002/cncr.27877.
Tabár L, Dean PB, Lindhe N, Ingvarsson M. The ongoing revolution in breast imaging calls for a similar revolution in breast pathology. Int J Breast Cancer. 2012;2012:489345. doi: 10.1155/2012/489345. Epub 2012 Sep 30.
Smith RA, Duffy SW, Tabár L. Breast cancer screening: the evolving evidence. Oncology (Williston Park). 2012 May;26(5):471-5, 479-81, 485-6. Review.
Yen AM, Duffy SW, Chen TH, Chen LS, Chiu SY, Fann JC, Wu WY, Su CW, Smith RA, Tabár L. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. Cancer. 2012 May 17. doi: 10.1002/cncr.27580
Tarján M, Chen HH, Tot T, Wu W, Lenngren A, Dean PB, Tabár L. Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers. Scand J Urol Nephrol. 2012 Aug;46(4):258-66. Epub 2012 Apr 23.
Bock K, Borisch B, Cawson J, Damtjernhaug B, de Wolf C, Dean P, den Heeten A, Doyle G, Fox R, Frigerio A, Gilbert F, Hecht G, Heindel W, Heywang-Köbrunner SH, Holland R, Jones F, Lernevall A, Madai S, Mairs A, Muller J, Nisbet P, O’Doherty A, Patnick J, Perry N, Regitz-Jedermann L, Rickard M, Rodrigues V, Del Turco MR, Scharpantgen A, Schwartz W, Seradour B, Skaane P, Tabár L, Tornberg S, Ursin G, Van Limbergen E, Vandenbroucke A, Warren LJ, Warwick L, Yaffe M, Zappa M. Effect of population-based screening on breast cancer mortality. Lancet. 2011 Nov 19;378(9805):1775-6.
Lander MR, Tabár L. Automated 3-D breast ultrasound as a promising adjunctive screening tool for examining dense breast tissue. Semin Roentgenol. 2011 Oct;46(4):302-8. Review.
Tabár L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011 Sep;260(3):658-63. Epub 2011 Jun 28.
Tot T, Gere M, Pekár G, Tarján M, Hofmeyer S, Hellberg D, Lindquist D, Chen TH, Yen AM, Chiu SY, Tabár L. Breast cancer multifocality, disease extent, and survival. Hum Pathol. 2011 Nov;42(11):1761-9. Epub 2011 Jun 12.
Tabár L, Dean PB. A new era in the diagnosis and treatment of breast cancer. Breast J. 2010 Sep-Oct;16 Suppl 1:S2-4. doi: 10.1111/j.1524-4741.2010.00992.x.
Tot T, Tabár L. The role of radiological-pathological correlation in diagnosing early breast cancer: the pathologist’s perspective. Virchows Arch. 2011 Feb;458(2):125-31. Epub 2010 Nov 3. Review.
Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, Viták B, Zackrisson S, Nyström L, Jonsson H. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2011 Feb 15;117(4):714-22. doi: 10.1002/cncr.25650. Epub 2010 Sep 29.
Chen LS, Yen AM, Duffy SW, Tabár L, Lin WC, Chen HH. Computer-aided system of evaluation for population-based all-in-one service screening (CASE-PASS): from study design to outcome analysis with bias adjustment. Ann Epidemiol. 2010 Oct;20(10):786-96.
Pashayan N, Pharoah P, Tabár L, Neal DE, Martin RM, Donovan J, Hamdy F, Duffy SW. Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence. Cancer Epidemiol. 2011 Apr;35(2):139-44. Epub 2010 Aug 16.
Chiu SY, Duffy S, Yen AM, Tabár L, Smith RA, Chen HH. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1219-28. Epub 2010 Apr 20.
Duffy SW, Tabár L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen. 2010;17(1):25-30. Erratum in: J Med Screen. 2010 Jun;17(2):106.
Holmberg L, Duffy SW, Yen AM, Tabár L, Vitak B, Nyström L, Frisell J. Differences in endpoints between the Swedish W-E (two county) trial of mammographic screening and the Swedish overview: methodological consequences. J Med Screen. 2009;16(2):73-80.
Tabár L, Dean PB. Thirty years of experience with mammography screening: a new approach to the diagnosis and treatment of breast cancer. Breast Cancer Res. 2008;10 Suppl 4:S3. Epub 2008 Dec 18.
Duffy SW, Tabár L, Chen TH, Yen AM, Dean PB, Smith RA. What information should be given to women invited for mammographic screening for breast cancer? Womens Health (Lond Engl). 2006 Nov;2(6):829-33.
The Swedish Organized Service Screening Evaluation Group. Duffy SW, Tabár L, Tony H.H. Chen et al. Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 1. Further Confirmation with Extended Data. Cancer Epidemiol Biomarkers Prev 2006;15(1):45-51.
The Swedish Organized Service Screening Evaluation Group. Duffy SW, Tabár L, Tony H.H. Chen et al. Reduction in Breast Cancer Mortality from Organized Service Screening with Mammography: 2. Validation with new analytic methods. Cancer Epidemiol Biomarkers Prev 2006;15:52-6.
Duffy SW, Tabár L, Vitak B, Warwick J. Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography? Breast J. 2006 Jan-Feb;12 Suppl 1:S91-5.
Tabár L, Tony Hsiu-His Chen, Amy Min-Fang Yen, Peter Dean. Detection, Diagnosis and Treatment of Early Breast Cancer Requires Creative Interdisciplinary Teamwork. Semin Breast Dis 8:4-9, 2005.
Duffy SW, Agbaje O, Tabár L, Vitak B, Bjurstam N, Bjorneld L, Myles JP, Warwick J. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res. 2005;7(6):258-65. Epub 2005 Nov 10.
Duffy SW, Smith RA, Tabár L. Re: Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst. 2005 Nov 16;97(22):1703; author reply 1703-4.
Duffy SW, Smith RA, Gabe R, Tabár L, Yen AM, Chen TH. Screening for breast cancer. Surg Oncol Clin N Am. 2005 Oct;14(4):671-97.
Tabár L, Tony Chen HH, Amy Yen MF, Tot T, Tung TH, Chen LS, Chiu YH, Duffy SW, Smith RA. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer. 2004 Oct 15;101(8):1745-59.
Smith RA, Duffy SW, Tabár L, Gabe R. Screening and early detection. In: Singletary SE, Robb GL, Hortobagyi GN, editors. Advanced Therapy of Breast Disease. Hamilton (Ontario): BC Decker Inc.; 2004.p.202-12.
Smith RA, Duffy SW, Gabe R, Tabár L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned? Radiol Clin North Am. 2004 Sep;42(5):793-806.
Tabár L, Vitak B, Yen MF, Chen HH, Smith RA, Duffy SW. Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J Med Screen. 2004;11(3):126-9.
Tabár L, Lebovic GS, Hermann GD, Kaufman CS, Alexander C, Sayre J. Clinical assessment of a radiolucent cushion for mammography. Acta Radiol. 2004 Apr;45(2):154-8
Warwick J, Tabár L, Vitak B, Duffy SW: Time-dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish Two-County Study. Cancer. 2004 Apr 1;100(7):1331-6.
Duffy SW, Tabár L, Vitak B, Day NE, Smith R, Chen HH, Yen MF: The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer. 2003 Aug;39(12):1755-60.
Yen MF, Tabár L, Vitak B, Smith RA, Chen HH, Duffy SW: Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ In breast cancer screening. Eur J Cancer. 2003 Aug;39(12):1746-54
Duffy SW, Tabár L, Vitak B, Yen MF, Warwick J, Smith RA, Chen HH: The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation. Ann Oncol. 2003 Aug;14(8):1196-8.
Tabár L, Yen MF, Vitak B, Chen HH, Smith RA, Duffy SW: Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003 Apr 26;361(9367):1405-10.
Myles JP, Nixon MR, Duffy SW, Tabár L, Boggis C, Evans G, Shenton A, Howell A: Bayesian evaluation of breast cancer screening using data from two studies. Stat Med. 2003 May 30;22(10):1661-74
Tabár L, Dean PB: Mammography and breast cancer: the new era. Int J Gynaecol Obstet. 2003 Sep;82(3):319-26. Review.
Tabár L, Smith RA, Vitak B, Yen MF, Chen HH, Warwick J, Myles JP, Duffy SW: Mammographic screening: a key factor in the control of breast cancer. Cancer J. 2003 Jan-Feb;9(1):15-27. Review.
Tabár L,: Mammographic Screening : Key Conclusions Supporting Screening Breast Journal. 2003 January/February; 9(Supplement):S7-S10
Duffy SW, Cuzick J, Tabár L, Vitak V, Chen HH, Yen MF, Smith RA: Correcting for non-compliance bias in case-control studies to evaluate cancer screening programs. App.Stat. 2002, 51,235-243
Duffy SW, Tabár L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, Sundbom A,
Tholin M, Wiege M, Akerlund A, Wu HM, Tung TS, Chiu YH, Chiu CP, Huang CC, Smith RA, Rosen M, Stenbeck M, Holmberg L: The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer. 2002 Aug 1;95(3):458-69
Tabár L, Duffy SW, Yen MF, Warwick J, Vitak B, Chen HH, Smith RA: All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point. J Med Screen. 2002;9(4):159-62
Duffy SW, Tabár L, Smith RA: The mammographic screening trials: commentary on the recent work by Olsen and Gotzsche. J Surg Oncol. 2002 Dec;81(4):159-62; discussion 162-6
Duffy SW, L Tabár, Smith RA: The Mammographic Screening Trials: Commentary on the Recent Work by Olsen and Gotzsche. CA Cancer J Clin, Vol 52, No 2, March/April 2002: pp 68-71
Tabár L, Smith RA, Duffy SW: Update on effects of screening mammography. Lancet. 2002 Jul 27;360(9329):337; author reply 339-40.
Gram IT, Funkhouser E, Nordgard L, Tabár L, Ursin G: Oral contraceptive use and mammographic patterns. Eur J Cancer Prev. 2002 Jun;11(3):265-70.
Tabár L, Duffy SW, Smith RA: Author Reply. Cancer, Vol 94, January 15, 2002: pp581-583
Heywang-Kobrunner SH, Bick U, Bradley WG Jr, Bone B, Casselman J, Coulthard A, Fischer U, Muller-Schimpfle M, Oellinger H, Patt R, Teubner J, Friedrich M, Newstead G, Holland R, Schauer A, Sickles EA, Tabár L, Waisman J, Wernecke KD: International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol. 2001;11(4):531-46.
Duffy SW, Tabár L, Smith RA: Screening for breast cancer with mammography. Lancet. 2001 Dec 22-29;358(9299):2166; author reply 2167-8.
Silverstein M J et al: Special report; international consensus conference. Image-Detected Breast Cancer: State of the Art Diagnosis and Treatment. Journal of the American College of Surgeons, Vol 193, No 3, September 2001: pp 297-302
Kaufman CS, Jacobson-Kaufman L, Thorndike-Christ T, Kaufman L, Tabár L: A treatment scale for axillary management in breast cancer. Am J Surg. 2001 Oct;182(4):377-83
Grogan M, Tabár L, Chua B, Chen HH, Boyages J: Estimating the benefits of adjuvant systemic therapy for women with early breast cancer. Br J Surg. 2001 Nov;88(11):1513-8
Warren Burhenne LJ, Smith RA, Tabár L, Dean PB, Perry N, Sickles EA: Mammographic screening: international perspective. Semin Roentgenol. 2001 Jul;36(3):187-94. Review
Tabár L, Vitak B, Chen HH, Yen MF, Duffy SW, Smith RA: Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality. Cancer. 2001 May 1;91(9):1724-31
Nixon RM, Pharoah P, Tabár L, Krusemo UB, Duffy SW, Prevost TC, Chen HH: Mammographic Screening in Women a Family History of Breast Cancer: Some Results From the Swedish Two-County Trial. Rev. Epidém. Et Santé Publ, No 48, 2000: pp 325-331
Tabár L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000;38:625-51.
Tabár L, Chen HH, Duffy SW, Yen MF, Chiang CF, Dean PB, Smith RA: A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet. 2000 Feb 5;355(9202):429-33. Erratum in: Lancet 2000 Apr 15;355(9212):1372.
Nixon RM, Prevost TC, Duffy SW, Tabár L, Vitak B, Chen HH: Some Random-Effects Models for the Analysis of Matched-Cluster Randomised Trials: Application to the Swedish Two-County Trial of Breast-cancer Screening. Journal of Epidemiology an d Biostatics, Vol 5, No 2000: pp 349-358
Tot T, Tabár L, Dean PB: The Pressing Need for Better Histologic-Mammographic Correlation of the Many Variations in Normal Breast Anatomy. Virchows Arch 2000, 437: pp 338-344
Warren Burhenne LJ, Wood SA, D’Orsi CJ, Feig SA, Kopans DB, O’Shaughnessy KF, Sickles EA, Tabár L, Vyborny CJ, Castellino RA: Potential contribution of computer-aided detection to the sensitivity of screening mammography. Radiology. 2000 May;215(2):554-62. Erratum in: Radiology 2000 Jul;216(1):306.
Tabár L et al: Image-Detected Breast Cancer: State of the Art Diagnosis and Treatment. Journal of the American College of Surgeons, Vol 193, No 3, September 2000: pp 297-302.
Tabár L, Duffy SW, Dean PB: Authors´reply. The Lancet, Vol 355, April 29 2000: pp 1552-155
Tabár L, Dean PB, Kaufman KS , Duffy SW, Chen HH: A New Era in the Diagnosis of Breast Cancer. Surgical Oncology Clinics of North America , Vol 9, no 2 April 2000: pp233-277
Chen HH, Kuo HS, Yen MF, Lai MS, Tabár L, Duffy SW: Estimation of Sojourn Time in Chronic Disease, Screening Without Data on Interval Cases. Biometrics, Vol 56, No 1 March 2000: pp 167-172
Tabár L, Duffy SW: Author reply. Cancer. 2000 Apr 1;88(7):1759
Tabár L, Chen HH, Duffy SW, Yen MF, Chiang CF, Dean PB, Smith RA: A Novel Method for Prediction of Long-term Outcome of Women with T1a, T1b and 10-14 mm Invasive Breast Cancers: a prospective study. Lancet, Vol 355, Feb 5, 2000, pp 429-433.
Duffy SW, Tabár L: Screening mammography re-evaluated. Lancet. 2000 Feb 26;355(9205):747-8; author reply 752